| Code | Description | Claims | Beneficiaries | Total Paid |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
161 |
121 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
62 |
59 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
24 |
23 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
119 |
114 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
90 |
84 |
$902.60 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
15 |
13 |
$809.10 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
14 |
$670.60 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18 |
13 |
$472.90 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$305.27 |
| 86756 |
|
21 |
21 |
$146.45 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
62 |
47 |
$113.47 |
| 83735 |
|
42 |
27 |
$74.41 |
| 82977 |
|
19 |
13 |
$43.42 |
| 80076 |
|
19 |
13 |
$41.34 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
21 |
14 |
$40.16 |
| 83615 |
|
19 |
13 |
$30.14 |
| 36415 |
Collection of venous blood by venipuncture |
172 |
128 |
$3.00 |